A) Prolixin B) Zyprexa C) Risperdal D) Geodon
A) Clozaril B) Invega C) Zyprexa D) Abilify
A) Seroquel B) Abilify C) Zyprexa D) Invega
A) Zyprexa B) Seroquel C) Risperdal D) Abilify
A) Abilify B) Geodon C) Risperdal D) Seroquel
A) Olanzapine B) Clozapine C) Quetiapine D) Ziprasidone
A) Aripriprazole B) Paliperidone C) Risperidone D) Ziprasidone
A) Geodon B) Risperdal C) Clozaril D) Seroquel
A) Ziprasidone B) Aripiprazole C) Paliperidone D) Clozapine
A) Quetiapine B) Paliperidone C) Risperdone D) Olazapine
A) Clozapine and Risperadone B) Risperidone and Paliperidone C) Aripiprazole and Paliperidone D) Clozapine and Aripiprazole
A) 4-5 B) 2-5 C) 1-3 D) 1
A) 6 B) 24 C) 18 D) 12
A) FALSE B) TRUE
A) Foster patients' medication compliance B) Prevent relapse into another psychotic episode C) Minimize side effects of medication D) Develop more adaptive coping skills
A) several weeks after discontinuation of medication B) one year after discontinuation of medication C) directly after discontinuation of medication D) six months after discontinuation of medication
A) Clozaril B) Thorazine C) Symmetrel D) Artane
A) enhanced efficacy in treatment-resistant patients B) tardive dyskinesia more common C) weight gain more common D) increased effectiveness for positive, negative, and disorganized symptoms
A) Risperidone B) Clozapine C) Haloperiodol D) Prochlorperazine
A) Anticonvulsants B) Stimulants C) Anxiolitics D) Alcohol
A) Alcohol B) Halperiodol C) Merperidine D) Beta blockers
A) Anticonvulsants B) Nicotine C) Beta blockers D) Antacids
A) Alcohol B) SSRIs C) Tricyclic antidepressants D) Beta blockers
A) TRUE B) FALSE
A) Tobacco use B) Drug holidays C) Male gender D) Alcohol use
A) TRUE B) FALSE
A) High potency antipsychotic drugs present greater risk for the development of tardive dyskinesia. B) The more frequent the dose of the antipsychotic medication, the greater the risk for the development of tardive dyskinesia. C) Classic antipsychotic medications present less risk for the development of tardive dyskinesia than atypical antipsychotic medications. D) All antipsychotic drugs but Clozapine present a significant risk for the development of tardive dyskinesia.
A) Akinesia B) Ataxia C) Acute dystonia D) Akathesia
A) Agranulocytosis B) Postural hypotension C) Gynecomastia D) Neuroleptic Malignant Syndrome
A) FALSE B) TRUE
A) TRUE B) FALSE
A) antagonize the normal dopamine-mediated inhibition of prolactin release. B) block D2 receptors in the pituitary gland and decrease prolactin secretion. C) block D2 receptors in the pituitary gland and inhibit prolactin secretion. D) agonize the normal dopamine-mediated inhibition of prolactin release.
A) neuroendocrine changes B) hungry hungry hippos C) molecular structure D) receptor binding and DA turnover
A) Butyrophenones B) Thioxanthenenes C) Phenothiazines D) Sleepykoaladones
A) Weak; high; lower B) Potent; low; lower C) Potent; low; higher D) Weak; high; higher
A) Delusions B) Hallucinations C) Formal thought disorder D) Anhedonia
A) Autoimmune diseases B) All of the above C) Endocrine disorders D) Metabolic disorders E) Neurological disorders
A) Alcohol B) All of the above C) Stimulants D) Opioids E) Hallucinogens
A) TRUE B) FALSE
A) All of the above. B) negative symptoms of Schizophrenia. C) positive symptoms of Schizophrenia. D) disorganized symptoms of Schizophrenia.
A) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine release. B) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine reuptake. C) blocking post-synaptic dopamine receptors and/or inhibiting dopamine reuptake. D) blocking post-synaptic dopamine receptors and/or inhibiting dopamine release.
A) the drug reduces the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine. B) the drug increases the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine. C) the drug reduces the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine. D) the drug increases the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine.
A) increased tap dancing B) increased rates of firing C) increased release of dopamine D) increased rates of synthesis
A) thioxanthenes B) piperideines C) piperazines D) aliphatics
A) genecomastia B) all of the above C) menstrual irregularity D) galactorrhea
A) Inapsine (droperiodol) B) Cogentin (benztropine) C) Artane (trihexphenidyl) D) Symmetrel (amantadine) E) Benadryl (diphenhydramine)
A) TRUE B) FALSE
A) polypharmacy B) actual impact at the biological level C) comparative lack of EPS D) superior impact on positive symptoms
A) Haldol B) Invega C) Clozaril D) Abilify
A) Seroquel B) Clorazil C) Risperdal D) Geodon |